The Harvard Drug Group LLC is recalling multiple lots of Major Pharmaceuticals Gabapentin Capsules (100 mg) due to the presence of an unknown impurity discovered during routine quality testing. Gabapentin is a prescription medication used to treat seizures and nerve pain. The recall affects both 100-count blister packs and 10-count outer bags distributed nationwide to pharmacies and healthcare facilities. You should consult your doctor or pharmacist if you have concerns about your medication, but do not stop taking it without professional advice.
Routine stability testing identified an 'out of specification' result for an unknown impurity, meaning the drug may degrade or contain substances above the safety limits established by the FDA. This could potentially reduce the medication's effectiveness or cause unexpected side effects.
You have 2 options:
Rx only; Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268
Blister pack NDC 0904-6665-61; Outer Bag NDC 55154-3363-0
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.